Has Carl Herndon, MD received payments from drug or device companies?

Yes. Drug and device makers reported $68,048 in general payments to Carl Herndon, MD across 116 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Carl Herndon, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Carl Herndon, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Carl Herndon, MD

Adult Reconstructive Orthopaedic Surgery · New York, NYNPI 1619321809

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $50,088 of the $68,048 with a category attached, or 73.6%. 11 manufacturers reported payments, led by Medical Device Business Services, Inc. at 57.3% of the total. Reporting peaked in 2024 at $40,381 and has fallen 52.1% since, to $19,342 in 2025.

$68,048in general payments, 2019–2025

Across 116 payments — averaging $586.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medical Device Business Services, Inc.$39K
Solventum Corporation$11K
Medtronic$5K
Depuy Synthes Products, Inc.$3K
Synthes GmbH$3K
Stryker$2K
plus $5K from 5 others

$3,350in research payments, 2019–2025

Across 1 payment — averaging $3350.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Polarisar Inc$3K

What the payments were for

Consulting fees$50,08874%
Speaking & faculty fees$6,2509%
Travel & lodging$4,3896%
Food & beverage$7,32211%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medical Device Business Services, Inc.	39	$38,986
Solventum Corporation	5	$10,909
Medtronic	2	$4,750
Depuy Synthes Products, Inc.	5	$3,357
Synthes GmbH	5	$2,982
Stryker	23	$2,285
Zimmer Biomet	11	$1,396
Johnson & Johnson(2 entities)	12	$1,234
KCI USA, Inc.	5	$1,078
Smith+Nephew	8	$957
Medacta USA, Inc.	1	$114

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$68,048 in reported general payments places this provider in the 75th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.

See all adult reconstructive orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$178,658

Medicare patients

451

Services billed

3,575

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Meloxicam	354	$933
Diclofenac Sodium ErDiclofenac Sodium	13	$875
Celecoxib	40	$640
Oxycodone Hcl	11	$43
Tramadol Hcl	13	$34

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in New York

Seth JerabekNew York$7.1M
Jose RodriguezNew York$3.4M
Friedrich BoettnerNew York$2.9M
Jonathan VigdorchikNew York$2.3M
William LongNew York$1.5M
Peter SculcoNew York$1.5M
Roshan ShahNew York$1.3M
Herbert CooperNew York$1.3M
Matthew AustinNew York$986K
Patrick MeereNew York$191K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →